NASDAQ$TEM

Tempus AI Inc · Q3 2025 earnings

Q3 2025 earnings · · After market close · Investor relations

Briefing

Tempus reported Q3 2025 total revenue of $334M with a net loss of $80M.

Total revenue grew to $334.2 million, up sharply year over year, driven by genomics and data/AI offerings including the Ambry acquisition contribution. The company posted a net loss of $80.0 million as it invests in scale and product expansion.

  • Q3 total revenue $334M (+85% YoY).
  • Net loss $80M.
  • Genomics revenue $253M in the quarter.
  • Ambry integration and AI/data platform investments continue.

Headline financials

Total Revenue

$334M

Previous: $181M+84.7%
EPS (adj)

-$0.11

Previous: -$0.25+56.0%
Capital Expenditures

-$16.3M

Previous: -$14.2M-15.1%
Free Cash Flow

-$96.3M

Previous: -$90M-7.0%
Net Income

-$80M

Previous: -$75.8M-5.5%
Operating Income

-$61M

Previous: -$53.6M-13.8%
Gross Profit

-$3.78M

Previous: -$3.72M-1.5%
Cash & Equivalents

$656M

Previous: $388M+69.0%
Total Assets

$2.28B

Previous: $972M+134.8%

Revenue & EPS history

Tempus AI Inc · Revenue · Quarterly

$334M

Q3 2025+84.7%vs Q3 2024
Beat estimate in 6 of 8 quarters(75%)
ActualEstimate

Revenue by segment

Tempus AI Inc · $146M total across 2 segments · Q1 2024

  • Diagnostics
    $103M
  • Data and Applications
    $43.3M

Forward guidance

The filing discusses Tempus AI's outlook, capital deployment, and key risks without relying solely on numeric EPS guidance.

Tailwinds

  • Tempus AI cited execution on strategic priorities in the filing.
  • Balance sheet and liquidity support continued operations.
  • Pipeline milestones and partnerships remain key value drivers.

Headwinds

  • GAAP profitability remained under pressure in the quarter.
  • Macro, competitive, and cost pressures may affect margins.
  • Segment mix and one-time items can affect comparability.
  • Pre-commercial or early-stage spend continues ahead of sustainable product revenue.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 9 quarterly earnings reports · overlaid with Q3 2025

Historical avgQ3 2025

-0.5%

Avg return

Earnings day

+10.9%

Avg return

5 days after

+15.2%

Avg return

30 days after

50%

5 / 10 earnings

Positive

+12.6%

Q1 2025

Best reaction

-15.0%

Q4 2024

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026-3.1%-10.7%
Q4 2025+3.6%-8.0%-26.5%
Q3 2025-2.7%-15.0%-9.3%
Q2 2025+3.4%+18.5%+35.5%
Q1 2025+12.6%+20.1%+18.9%
Q4 2024-15.0%-19.2%-25.3%
Q3 2024-3.4%+60.2%+25.9%
Q3 2023-3.4%+60.2%+25.9%
Q2 2024+1.6%+1.4%+45.6%
Q2 2023+1.6%+1.4%+45.6%
Q1 2024
Q1 2023
Q4 2022
Q3 2021
Q3 2020

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro